Fronto-temporal tDCS Mproves Fluency & Empathy in ASD Kids
NCT ID: NCT02004236
Last Updated: 2024-09-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
225 participants
INTERVENTIONAL
2014-02-28
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autism Spectrum Disorders: Double Blind Randomized Placebo-control Active Pilot Study of Transcranial Magnetic Stimulation Applied to the Superior Temporal Sulcus
NCT04442061
Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With ASD
NCT05492032
High Definition Transcranial Direct Current Stimulation of Right Inferior Frontal Gyrus to Improve Social Impairments in Children with Autism
NCT06723522
Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents
NCT06272669
Investigation of Brain Plasticity in Autism Spectrum Disorders
NCT04706364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tRNS Fronto-temporal cortex
This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex
This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS over fusiform temporal cortex
This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex
This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS with sham
This group receive 35 sessions with sham
tRNS with sham
the subjects receive 35 session with sham
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tRNS Fronto-temporal cortex
This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS over fusiform temporal cortex
This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS with sham
the subjects receive 35 session with sham
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet DSM-IV criteria for autism spectrum disorder.
* Patients who have been diagnosed at least 2 years before inclusion in the study.
Exclusion Criteria
* Traumatic brain injury.
* Other neurological disorders: migraine, epilepsy, tuberous sclerosis ...
* Trauma at birth.
* Mental retardation.
* Pregnancy.
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spanish Foundation for Neurometrics Development
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Neville, MD
Role: PRINCIPAL_INVESTIGATOR
New Remedies Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Remedies Ltd
Liverpool, Merseyside, United Kingdom
Moises Aguilar Domingo
Liverpool, Spain, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Autism and tDCS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.